Crona CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
CCCP
Crona CORPCrona Corp. reported a net profit for Q3 2025, primarily driven by significant debt forgiveness, despite continuing to generate no revenue and facing substantial doubt about its ability to continue as a going concern.
OTC.Pink
CCCP
Crona CORPCrona Corp. filed an amended quarterly report to update its industry classification, clarify business activities in funeral services, and correct previously misstated stock balances.
OTC.Pink
CCCP
Crona CORPCrona Corp.'s Q2 2025 report reveals no revenue, a significant increase in net loss, and substantial doubt about its ability to continue as a going concern, despite a strategic shift to the memorialization industry.
OTC.Pink
CCCP
Crona CORPCrona Corp. reports no revenue for Q1 2025, focusing on its antimicrobial surface protection business and managing ongoing financial challenges.
OTC.Pink
CCCP
Crona CORPCrona Corp. reports its third quarter 2024 results, showing no revenue and a net loss, while continuing its transition into the memorialization industry.
OTC.Pink
CCCP
Crona CORPCrona Corp. reported no revenue and a net loss of $44,945 for the six months ended June 30, 2024, as it transitions into the memorialization industry.
OTC.Pink
CCCP
Crona CORPCrona Corp. reports a net loss of $17,838 for the first quarter of 2024, transitioning from antimicrobial services to the memorialization industry.
OTC.Pink
CCCP
Crona CORPCrona Corp. reports its financial results for the third quarter of 2023, showing a net loss and a shift in business focus from antimicrobial services to the memorialization industry.